AI healthcare buzz lifts the Hang Seng Index; Hsi Esg Enhanced Select Index Etf (03136.HK) surges more than 1.5%.
NewTimeSpace, 13 Jan – AI-healthcare and tech-heavyweights ignited Hong Kong, pushing the Hang Seng Index 2 % higher by late morning. At 11:12 a.m. the Hsi Esg Enhanced Select Index Etf (03136.HK) was up more than 1.5 % intraday.
Listed data show 03136.HK – launched by Hang Seng Investment Management – is the first local ETF directly tracking the Hang Seng ESG 50 Index. Marketed as “one-click access to Hong Kong’s ESG high-flyers”, it blends sustainability screens with core-equity exposure.
The benchmark holds 50 locally listed leaders screened for ESG scores and excludes controversial sectors. Heavyweights range from dividend-rich HSBC, AIA and HKEX to new-economy names such as WuXi Biologics and Sunny Optical, giving the basket an “old-economy stability plus new-economy momentum” balance.
NewTimeSpace Research adds that Hang Seng Tech is now primed for a “Davies triple-play” of upward earnings revisions, valuation re-rating and returning south-bound flows, leaving AI-application names with high risk-adjusted odds over the medium term. HK high-dividend stocks retain a tax-exempt edge for onshore insurers, keeping them ahead of their A-share peers. The innovation-drug complex is gaining twin leverage from narrowing China-U.S. price gaps, while the new-consumption segment looks poised to replay the 2019-21 core-asset bull market as policy tailwinds and traffic-driven monetisation spark re-rating.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- NewTimeSpace Stars | Diagens Biotechnology Re-submits to HKEX, Aiming to Become the First Stock of AI Chromosome Diagnosis
- Export-tax rebate scrapped—solar sector jolted; Csop Huatai-Pinebridge Csi Photovoltaic Industry Etf (03134.HK) tumbles more than 3% intraday.
- JPM Conference kicks off—CSOP Hang Seng Biotech ETF (03174.HK) and Chinaamc Hang Seng Hong Kong Biotech Index ETF (03069.HK) both surge over 3%.
- “Hong Kong’s new regulations take effect + RWA compliance clarified, A PanDu Blockchain (03112.HK) surges over 3.6%.”
- Core Logic of AI Commercialization from Unique Research’s CES Dialogue: Abandon Internet Mindset, Shift to Hybrid "Tiered Subscription + Usage Limits" Model